{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:27:15Z","timestamp":1782602835331,"version":"3.54.5"},"reference-count":118,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1586\/14760584.7.1.97","type":"journal-article","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T12:15:18Z","timestamp":1202213718000},"page":"97-115","source":"Crossref","is-referenced-by-count":61,"title":["Combination vaccines containing DTPa\u2013Hib: impact of IPV and coadministration of CRM197 conjugates"],"prefix":"10.1586","volume":"7","author":[{"given":"Ron","family":"Dagan","sequence":"first","affiliation":[{"name":"Pediatric Infectious Disease Unit, Soroka University Medical Center, PO Box 151, Beer-Sheva 84101, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan T","family":"Poolman","sequence":"additional","affiliation":[{"name":"Bacterial Vaccines, GlaxoSmithKline Biologicals, Rue de l\u2019Institut 89, 1330 Rixensart, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Zepp","sequence":"additional","affiliation":[{"name":"Dept. of Pediatrics, Johannes Gutenberg-University Mainz, Langenbeckstrasse 1, D-55131 Mainz, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.2.302-317.2000"},{"key":"e_1_3_2_4_1","doi-asserted-by":"crossref","unstructured":"Eskola J Ward J Dagan R Goldblatt D Zepp F Siegrist CA. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria\u2013tetanus\u2013pertussis containing acellular pertussis. Lancet354(9195) 2063\u20132068 (1999).","DOI":"10.1016\/S0140-6736(99)04377-9"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.86.6.396"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.052720"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.60.5.730"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.74.5.857"},{"key":"e_1_3_2_9_1","unstructured":"Schneerson R Robbins JB Szu SC Yang Y. Vaccines composed of polysaccharide-protein conjugates:current status unanswered questions and prospects for the future. In: Towards Better Carbohydrate Vaccines. Bell R Torrigiani G (Eds). John Wiley & Sons NY USA307\u2013331 (1987)."},{"key":"e_1_3_2_10_1","doi-asserted-by":"crossref","unstructured":"Anderson PW Pichichero ME Stein EC et al. Effect of oligosaccharide chain length exposed terminal group and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen uniterminally coupled to the diphtheria protein CRM197. J. Immunol.142(7) 2464\u20132468 (1989).","DOI":"10.4049\/jimmunol.142.7.2464"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(87)80540-1"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.138.2.587"},{"key":"e_1_3_2_13_1","first-page":"256","volume":"23","author":"Granoff","year":"1988","unstructured":"Granoff DM, Sheetz KE, Nahm MH, Madassery JV, Shackelford PG. Further immunologic evaluation of children who develop Haemophilus disease despite previous vaccination with type b polysaccharide vaccine. Monogr. Allergy23, 256\u2013268 (1988).","journal-title":"Monogr. Allergy"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(87)80336-0"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1006\/biol.1994.1062"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116298"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199306000-00006"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92863-6"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80424-X"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365549609037951"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.12.5345-5350.1993"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83428-6"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480110065035"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.154.8.4195"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011153232006"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03500020055031"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid0203.960303"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/164.5.982"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83529-2"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1086\/517440"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199504000-00008"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199306000-00005"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199307000-00009"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198710083171503"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/147.6.1100"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/149.6.1034"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1086\/322563"},{"key":"e_1_3_2_38_1","doi-asserted-by":"crossref","unstructured":"Singleton R Hammitt L Hennessy T et al. The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease. Pediatrics118(2) e421\u2013e429 (2006).","DOI":"10.1542\/peds.2006-0287"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1086\/314989"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00517-X"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011153232004"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00154-07"},{"key":"e_1_3_2_43_1","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1128\/iai.60.11.4838-4847.1992","volume":"60","author":"Bredius","year":"1992","unstructured":"Bredius RG, Driedijk PC, Schouten MF, Weening RS, Out TA. Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid. Infect. Immun.60(11), 4838\u20134847 (1992).","journal-title":"Infect. Immun."},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.1.163"},{"key":"e_1_3_2_45_1","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/bmj.316.7144.1569","volume":"316","author":"Goldblatt","year":"1998","unstructured":"Goldblatt D, Miller E, McCloskey N, Cartwright K. Immunological response to conjugate vaccines in infants: follow up study. BMJ316, 1569\u20131570 (1998).","journal-title":"BMJ"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1086\/317646"},{"key":"e_1_3_2_47_1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0022-3476(96)70436-5","volume":"128","author":"Pallares","year":"1996","unstructured":"Pallares DE, Figueroa JE, Densen P, Giclas PC, Marshall GS. Invasive Haemophilus influenzae type b infection in a child with familial deficiency of the beta subunit of the eighth component of complement. J. Pediatr.128(1), 102\u2013103 (1996).","journal-title":"J. Pediatr."},{"key":"e_1_3_2_48_1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/infdis\/154.6.935","volume":"154","author":"Musher","year":"1986","unstructured":"Musher D, Goree A, Murphy T et al. Immunity to Haemophilus influenzae type b in young adults: correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination. J. Infect. Dis.154(6), 935\u2013943 (1986).","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050797"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1086\/514741"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00241-7"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2005.10.014"},{"key":"e_1_3_2_53_1","first-page":"243","volume":"25","author":"Halperin","year":"2002","unstructured":"Halperin SA, McDonald J, Samson L et al. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria\u2013tetanus\u2013acellular pertussis\u2013inactivated poliovirus\u2013Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study. Clin. Invest. Med.25(6), 243\u2013251 (2002).","journal-title":"Clin. Invest. Med."},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200108000-00010"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000141743.74443.73"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1206.051451"},{"key":"e_1_3_2_57_1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0264-410X(99)00238-8","volume":"18","author":"Carlsson","year":"2000","unstructured":"Carlsson RM, Claesson BA, K\u00e4yhty H, Selstam U, Iwarson S. Studies on a Hib\u2013tetanus toxoid conjugate vaccine: effects of coadministered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine. Vaccine18(5\u20136), 468\u2013478 (2000).","journal-title":"Vaccine"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200110000-00011"},{"key":"e_1_3_2_59_1","doi-asserted-by":"crossref","unstructured":"Blatter MM Reisinger KS Terwelp DR DelBuono FJ Howe BJ. Immunogenicity of a combined diphtheria\u2013tetanus\u2013acellular pertussis (DT\u2013tricomponent Pa)\u2013hepatitis B (HB)\u2013inactivated poliovirus (IPV) admixed with Haemophilus influenzae type b (Hib) vaccine in infants. Presented at: American Pediatric Society and the Society for Pediatric Research. LA USA. 1\u20135 May 1998 (Abstract 813).","DOI":"10.1203\/00006450-199804001-00834"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-002-1079-5"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.02.013"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00420-1"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200005000-00006"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.12.8130-8135.2005"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2004.01971.x"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200007000-00001"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13171-6"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16725-1"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1995.tb44436.x"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.18.2334"},{"key":"e_1_3_2_71_1","first-page":"E060302.4","volume":"11","author":"Cameron","year":"2006","unstructured":"Cameron C, Pebody R. Introduction of pneumococcal conjugate vaccine to the UK childhood immunization programme, and changes to the meningitis C and Hib schedules. Eurosurveillance11(3), E060302.4 (2006).","journal-title":"Eurosurveillance"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)06392-1"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12441-5"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.1.3.399"},{"key":"e_1_3_2_75_1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s004310050601","volume":"156","author":"von","year":"1997","unstructured":"von Kries R, B\u00f6hm O, Windfuhr A. Haemophilus influenzae b-vaccination: the urgency for timely vaccination. Eur. J. Pediatr.156(4), 282\u2013287 (1997).","journal-title":"Eur. J. Pediatr."},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1086\/318132"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1086\/324666"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1086\/314901"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000207483.60267.e7"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.07.060"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00299-7"},{"key":"e_1_3_2_82_1","unstructured":"Habermehl P Leroux-Roels G S\u00e4nger R M\u00e4chler G Boutriau D. Immunogenicity and Reactogenicity of a combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y\u2013tetanus toxoid conjugate (Hib\u2013MenCY\u2013TT) vaccine administered as a primary at 2 3\u20134 months and as a booster at second year of life. Presented at: 15th International Pathogenic Neisseria Conference Cairns Australia 10\u201315 September 2006. (Abstract)."},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00377-06"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000145427.19167.35"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.03.032"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000148923.46453.48"},{"key":"e_1_3_2_87_1","doi-asserted-by":"crossref","unstructured":"Tozzi AE Azzari C Bartolozzi G Esposito S Fara GM Giudice ML. Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines? Hum. Vaccin.23 3\u2013(6) (2007).","DOI":"10.4161\/hv.4626"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.11.021"},{"key":"e_1_3_2_89_1","unstructured":"Olivier C Liese JG Stojanov S et al. Immunogenicity and safety of the 7-valent pneumococcal conjugate vaccine (7vPNC\u2013Prevenar) coadministered with a hexavalent DTaP\u2013IPV\u2013HBV\u2013Hib Vaccine (Hexavac). Poster G-836. Presented at: The 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy CA USA 27\u201330 September 2002."},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.5.2093-2098.1998"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.9.5383-5391.2004"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1185\/0300799039117063"},{"key":"e_1_3_2_93_1","first-page":"2738","volume":"149","author":"Spanjaard","year":"2005","unstructured":"Spanjaard L, van den Hof S, de Melker HE, Vermeer-de Bondt PE, van der Ende A, Rijkers GT. Increase in the number of invasive Haemophilus influenzae type b infections. Ned. Tijdschr. Geneeskd.149(49), 2738\u20132742 (2005).","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268804002122"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91802-H"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00050-0"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007999909113370"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199912000-00019"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200103000-00002"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.88.3.206"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.2.356"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1086\/432548"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.6.2741-2749.2005"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.5.1645-1649.2006"},{"key":"e_1_3_2_105_1","first-page":"1","volume":"33","author":"National","year":"2007","unstructured":"National Advisory Committee on Immunization (NACI). Statement on the recommended use of pentavalent and hexavalent vaccines. Can. Commun. Dis. Rep.33(Suppl. 3) 1\u201316 (2007).","journal-title":"Can. Commun. Dis. Rep."},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.14.1751"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200009000-00009"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199603000-00008"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91400-1"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1994.02170060074015"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199102000-00004"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199102000-00003"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09267-7"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199811000-00013"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200012000-00001"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200205000-00010"},{"key":"e_1_3_2_117_1","doi-asserted-by":"crossref","unstructured":"Kitchin N Southern J Morris R et al. Evaluation of a diphtheria\u2013tetanus\u2013acellular pertussis\u2013inactivated poliovirus\u2013Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2 3\u20134 months of age. Arch. Dis. Child.92 11\u201316 (2007).","DOI":"10.1136\/adc.2005.076109"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2000.107796"},{"key":"e_1_3_2_119_2_1","unstructured":"Gilca V Duval B. Literature review on DTaP based penta- and hexavalent vaccines approved for clinical use in Canada. Institut national de sant\u00e9 publique du Qu\u00e9bec Canada (2006) www.phac-aspc.gc.ca\/naci-ccni\/l_review_e.html"},{"key":"e_1_3_2_119_3_1","unstructured":"US FDA briefing document for pentacel: diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed inactivated poliovirus and Haemophilus b conjugate (tetanus toxoid conjugate) vaccine combined (2007) www.fda.gov\/ohrms\/dockets\/ac\/07\/briefing\/2007\u20134275B1\u201302.pdf"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14760584.7.1.97","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:20:33Z","timestamp":1772713233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14760584.7.1.97"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1586\/14760584.7.1.97"],"URL":"https:\/\/doi.org\/10.1586\/14760584.7.1.97","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}